Reacts specifically with Sialyl Lewis a containing glycolipids, without detectable reactivity with Lewis a, Lewis b or structurally related substances as determined by solid-phase binding assays against glycolipid antigens. Shows minimal cross-reactivity (<1%) with Sialyl Lacto-N-tetraosylceramide.
Produktmerkmale
Host: Hybridization of NS-1 myeloma cells with spleen cells from Balb/c mice.
CA 19-9
Reaktivität: Human
IHC, ELISA, FACS, IF, IRMA, Inh
Wirt: Human
Monoclonal
7E3#
unconjugated
Applikationshinweise
Capture antibody in serological assays for the research of CA 19-9. Immunohistochemistry on frozen or paraffin sections for the detection of Sialyl Lewis a. Immunochemical detection of Sialyl Lewis a determinant in mucins and glycolipids.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1:1000~5000
Buffer
0.01M PBS, pH7.4
Lagerung
4 °C
Target
CA 19-9
(Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
Andere Bezeichnung
CA 19-9
Hintergrund
Monoclonal Antibody to Human Cancer Antigen CA 19-9 (Gastrointestinal Cancer)